Literature DB >> 31907569

18F-FDG PET/CT feature of pancreatic adenosquamous carcinoma with pathological correlation.

Weiwei Su1, Shuai Zhao1, Ying Chen2, Changjing Zuo1, Bin Cui1, Minjie Wang3, Fangyuan Ren4.   

Abstract

PURPOSE: To investigate 18F-FDG PET/CT feature of pancreatic adenosquamous carcinoma (PASC) in contrast with conventional pancreatic ductal adenocarcinoma (PDAC), and its correlation with pathological findings. PATIENTS AND METHODS: Patients with PASC or PDAC confirmed by surgical pathology, who underwent FDG PET/CT scanning before surgical resection, were retrospectively studied. PASC group and conventional PDAC group included 13 and 104 patients, respectively. Delayed phase of PET/CT scanning was performed in 12 patients with PASC and 99 with PDAC. Maximum standardized value (SUVmax) was measured, and the mean retention index (RI) was calculated by ([PET120min SUVmax]-[PET 60min SUVmax]) ÷ PET 60min SUVmax × 100%.
RESULTS: On PET/CT, all lesions of PASC group showed intense FDG uptake, and the SUVmax were significantly higher than the lesions of conventional PDAC group both on the early [10.43 ± 5.10 (4.37-24.00) vs. 7.31 ± 3.86 (1.93-21.08), P = 0.011] and delayed phase [13.29 ± 6.04 (5.72-28.16) vs. 8.84 ± 5.14 (1.92-27.58), P = 0.005]. On the delayed phase, all lesions of PASC group had increased SUVmax with positive RI value (27.04% ± 8.87%, 7.14-39.27%). For conventional PDAC group, 81 lesions had increased SUVmax with positive RI value (27.25% ± 19.10%, 1.09-104.49%), while eighteen (18.18%) lesions of PDAC group had slightly decreased SUVmax, and their RI value were negative (- 11.35% ± 13.50%, - 43.17 to - 0.14%). The proliferative index (Ki-67) of lesions of PASC group was positively correlated with both the early (P = 0.034, r = 0.671) and delayed SUVmax (P = 0.019, r = 0.721). The RI value of lesions with adjacent organ invasion in PASC group was significantly higher than those without invasion (33.25% ± 4.92% vs. 20.83% ± 7.49%, P = 0.007).
CONCLUSION: PASC has more intense FDG uptake than conventional PDAC both on early and delayed phase. RI value of PASC was positive. Negative RI value may be helpful for differentiating PDAC from PASC. SUVmax and RI value may be helpful for prediction of its malignancy and invasion.

Entities:  

Keywords:  FDG PET/CT; Pancreatic adenosquamous carcinoma; Pancreatic ductal adenocarcinoma; Retention index

Mesh:

Substances:

Year:  2020        PMID: 31907569     DOI: 10.1007/s00261-019-02393-6

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  16 in total

1.  Adenosquamous carcinoma of the pancreas.

Authors:  G V Aranha; S Yong; M Olson
Journal:  Int J Pancreatol       Date:  1999-10

Review 2.  Surgical outcome of adenosquamous carcinoma of the pancreas.

Authors:  Takehiro Okabayashi; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

3.  415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival.

Authors:  Casey A Boyd; Jaime Benarroch-Gampel; Kristin M Sheffield; Catherine D Cooksley; Taylor S Riall
Journal:  J Surg Res       Date:  2011-07-07       Impact factor: 2.192

4.  Adenosquamous Carcinoma of the Pancreas Demonstrated on 18F-FDG PET/CT Imaging.

Authors:  Lei Jiang; Hongting Nie; Lei Zhu; Yan Xiu; Hongcheng Shi
Journal:  Clin Nucl Med       Date:  2017-03       Impact factor: 7.794

Review 5.  Adenosquamous carcinoma of the pancreas.

Authors:  J A Madura; B T Jarman; M G Doherty; M N Yum; T J Howard
Journal:  Arch Surg       Date:  1999-06

Review 6.  Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review.

Authors:  Erkut Borazanci; Sherri Z Millis; Ron Korn; Haiyong Han; Clifford J Whatcott; Zoran Gatalica; Michael T Barrett; Derek Cridebring; Daniel D Von Hoff
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

7.  Clinical characteristics of adenosquamous carcinoma of the pancreas: a matched case-control study.

Authors:  Hiroshi Imaoka; Yasuhiro Shimizu; Nobumasa Mizuno; Kazuo Hara; Susumu Hijioka; Masahiro Tajika; Shinya Kondo; Tsutomu Tanaka; Takeshi Ogura; Tomohiko Obayashi; Toshiyuki Hasegawa; Yasumasa Niwa; Kenji Yamao
Journal:  Pancreas       Date:  2014-03       Impact factor: 3.327

8.  Adenosquamous carcinoma of pancreas: CT and MR imaging features in eight patients, with pathologic correlations and comparison with adenocarcinoma of pancreas.

Authors:  Fumihito Toshima; Dai Inoue; Kotaro Yoshida; Norihide Yoneda; Tetsuya Minami; Satoshi Kobayashi; Hiroko Ikdeda; Osamu Matsui; Toshifumi Gabata
Journal:  Abdom Radiol (NY)       Date:  2016-03

9.  Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.

Authors:  Rory L Smoot; Lizhi Zhang; Thomas J Sebo; Florencia G Que
Journal:  J Am Coll Surg       Date:  2008-05-15       Impact factor: 6.113

10.  Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma.

Authors:  Jun-Te Hsu; Han-Ming Chen; Ren-Chin Wu; Chun-Nan Yeh; Ta-Sen Yeh; Tsann-Long Hwang; Yi-Yin Jan; Miin-Fu Chen
Journal:  World J Surg Oncol       Date:  2008-09-03       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.